AMGEN TO PRESENT AT CITI'S 2026 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT

Rhea-AI Summary

Amgen (NASDAQ:AMGN) will present at Citi's 2026 Virtual Oncology Leadership Summit on Wednesday, Feb. 18, 2026 at 12:15 p.m. PT. Jean-Charles Soria, senior vice president of oncology within global development, will deliver the presentation.

The presentation will be webcast live and archived for at least 90 days on Amgen's investor website, with timing and links listed on the Investor Relations Events Calendar.

Key Figures

Summit time: 12:15 p.m. PT Summit date: Feb. 18, 2026 Webcast archive period: 90 days +5 more

8 metrics

Summit time 12:15 p.m. PT Citi 2026 Virtual Oncology Leadership Summit presentation time

Summit date Feb. 18, 2026 Scheduled date of Amgen’s presentation

Webcast archive period 90 days Minimum replay availability after the event

Current price $366.20 Price before summit news, within 5% of 52-week high

52-week high $385.12 Upper end of AMGN’s 52-week trading range

52-week low $261.43 Lower end of AMGN’s 52-week trading range

20-day avg volume 3,224,117 Benchmark for comparing current trading activity

FY 2025 revenue $36.8 billion Total revenues, up 10% year-over-year (historical event)

Market Reality Check

Price: $366.20 Vol: Volume 2,260,731 is 0.7x ...

normal vol

$366.20 Last Close

Volume Volume 2,260,731 is 0.7x the 20-day average, indicating muted trading interest ahead of the event. normal

Technical Shares at 366.20 are trading above the 200-day MA of 304.72, reflecting a longer-term uptrend into this conference.

Peers on Argus

AMGN’s move of -0.1% occurred alongside mixed large-cap pharma peers: GILD -1.05...

1 Down

AMGN’s move of -0.1% occurred alongside mixed large-cap pharma peers: GILD -1.05%, PFE -0.65%, BMY -0.23%, while SNY +0.21% and GSK +0.19%. Only AZN appeared in the momentum scanner, moving down, suggesting today’s setup is more stock-specific than a broad sector rotation.

Historical Context

5 past events · Latest: Feb 03 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 03	Earnings results	Positive	-1.8%	Reported FY 2025 revenue and EPS growth with mixed product performance.
Jan 28	Earnings webcast	Neutral	+0.2%	Announced timing and access details for Q4 and full-year 2025 webcast.
Jan 20	Legal news	Negative	+0.2%	Headline about lawsuit over prescription drug access involving a large pharma.
Jan 07	Conference presentation	Neutral	-3.4%	J.P. Morgan Healthcare Conference presentation with webcast access details.
Jan 06	Acquisition deal	Positive	+3.0%	Announced Dark Blue Therapeutics acquisition to expand oncology portfolio.

Pattern Detected

Recent news often shows price reactions that diverge from headline tone, with several positive or neutral items followed by negative moves.

Recent Company History

Over the past months, AMGN has reported solid financial growth and strategic activity. Q4 and full-year 2025 results on Feb 03 showed revenue and EPS growth but the stock fell 1.77%. An earlier webcast announcement on Jan 28 saw a slight 0.21% gain. A Dark Blue Therapeutics acquisition on Jan 06 for up to $840 million coincided with a 2.95% rise, while conference and general news on Jan 07 and Jan 20 produced modest, mixed reactions. Today’s conference appearance fits this pattern of frequent investor events.

Market Pulse Summary

This announcement highlights AMGN’s participation in Citi’s 2026 Virtual Oncology Leadership Summit,...

Analysis

This announcement highlights AMGN’s participation in Citi’s 2026 Virtual Oncology Leadership Summit, with a webcast at 12:15 p.m. PT on Feb. 18, 2026 and replay access for at least 90 days. It continues a pattern of high investor-relations visibility through major healthcare and oncology forums. Investors may focus on how the oncology strategy discussed here connects to prior acquisitions and recent financial performance while monitoring future updates following the event.

Key Terms

oncology, webcast, investor relations

3 terms

oncology medical

"Citi's 2026 Virtual Oncology Leadership Summit at 12:15 p.m. PT"

Oncology is the branch of medicine focused on understanding, diagnosing, and treating cancer, including the development and testing of drugs, therapies, and screening methods. It matters to investors because advances, trial results, regulatory approvals, or setbacks in cancer research can dramatically change the value of companies and the size of potential markets—think of oncology news as weather reports that help investors steer financial decisions in a high-stakes field.

webcast technical

"The webcast will be broadcast over the internet simultaneously"

A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

investor relations financial

"can be found on Amgen's website, www.amgen.com, under Investors"

Investor relations is the communication process between a company and its current or potential investors. It involves sharing information about the company's performance, strategies, and outlook to help investors make informed decisions. Effective investor relations build trust and transparency, similar to a clear conversation between a business and someone considering investing, ensuring both parties understand each other's interests and expectations.

AI-generated analysis. Not financial advice.

THOUSAND OAKS, Calif., Feb. 13, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citi's 2026 Virtual Oncology Leadership Summit at 12:15 p.m. PT on Wednesday, Feb. 18, 2026. Jean-Charles Soria, senior vice president of oncology within global development at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public. 

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event. 

About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines. 

More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, heart disease, inflammatory conditions, rare diseases and obesity and obesity-related conditions.

Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average^®, and it is also part of the Nasdaq-100 Index^®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.

For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, YouTube, Facebook, TikTok and Threads. 

CONTACT: Amgen, Thousand Oaks 
Elissa Snook, 609-251-1407 (media)
Casey Capparelli, 805-447-1746 (investors)

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-citis-2026-virtual-oncology-leadership-summit-302687989.html

SOURCE Amgen

FAQ

When will Amgen (AMGN) present at Citi's 2026 Virtual Oncology Leadership Summit?

Amgen will present on Wednesday, Feb. 18, 2026 at 12:15 p.m. PT. According to the company, the presentation is scheduled for that date and time and will be delivered by Jean-Charles Soria, senior vice president of oncology within global development.

Who is presenting for Amgen (AMGN) at the Feb. 18, 2026 oncology summit?

Jean-Charles Soria, Amgen's senior vice president of oncology within global development, will present. According to the company, Soria will speak at 12:15 p.m. PT and represent Amgen's oncology development team during the webcast.

How can investors watch Amgen (AMGN) at Citi's 2026 Virtual Oncology Leadership Summit?

The presentation will be webcast live and available online to investors and the public. According to the company, webcast links and timing are posted on Amgen's Investor Relations Events Calendar and archived for at least 90 days.

Will the Amgen (AMGN) webcast from Citi's 2026 summit be archived for replay?

Yes. The webcast will be archived and available for replay for at least 90 days after the event. According to the company, the archived webcast can be accessed via Amgen's investor website under Events or Presentations.

Where does Amgen (AMGN) publish details and links for the Feb. 18, 2026 presentation?

Amgen posts presentation times and webcast links on its Investor Relations Events Calendar. According to the company, viewers should check the Amgen investor website for exact timing, live webcast access, and archived replay information.